Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
DexCom (DXCM) PT Raised to $140 at Jefferies
February 10, 2023 8:13 AM ESTJefferies analyst Matthew Taylor raised the price target on DexCom (NASDAQ: DXCM) to $140.00 (from $135.00) while maintaining a Buy rating following earnings.
The analyst commented, "DXCM reported 4Q sales of $815.2MM +20% organic, and reiterated guidance for the year. As a reminder, DXCM... More
DexCom (DXCM) Tops Q4 EPS by 7c
February 9, 2023 4:06 PM ESTDexCom (NASDAQ: DXCM) reported Q4 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2 million versus the consensus estimate of $809.35 million.
GUIDANCE:
DexCom sees Q1 2023 revenue of $3.35-3.49 billion, versus the consensus of $3.47... More
